These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6165457

  • 1. Combined interferon--antimetabolite therapy of murine L1210 leukemia.
    Slater LM, Wetzel MW, Cesario T.
    Cancer; 1981 Jul 01; 48(1):5-9. PubMed ID: 6165457
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D, Hilliard SL.
    Cancer Res; 1978 Aug 01; 38(8):2317-20. PubMed ID: 667827
    [No Abstract] [Full Text] [Related]

  • 3. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA, Hutchison DJ.
    Cancer Chemother Rep; 1972 Aug 01; 56(4):473-81. PubMed ID: 5081590
    [No Abstract] [Full Text] [Related]

  • 4. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K, Robak T.
    Acta Haematol Pol; 1992 Aug 01; 23(1):55-62. PubMed ID: 1615753
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.
    Harrison SD, Stevens JJ, Waud WR, Dykes DJ, Schmid SM, Griswold DP.
    J Biol Response Mod; 1990 Aug 01; 9(4):395-400. PubMed ID: 2118561
    [Abstract] [Full Text] [Related]

  • 6. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
    Machida S, Ito Y, Hoshino A.
    Gan To Kagaku Ryoho; 1985 Feb 01; 12(2):298-302. PubMed ID: 3918506
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR, Atkins LM, Meischen SJ, Smith AB, Walker EM.
    J Natl Cancer Inst; 1976 Dec 01; 57(6):1363-6. PubMed ID: 187805
    [Abstract] [Full Text] [Related]

  • 8. Single versus combination chemotherapy of L1210 leukemia.
    Koza I, Balázová E, Ujházy V.
    Neoplasma; 1980 Dec 01; 27(6):691-6. PubMed ID: 7254424
    [Abstract] [Full Text] [Related]

  • 9. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
    Zagozdzon R, Gołab J, Stokłosa T, Giermasz A, Nowicka D, Feleszko W, Lasek W, Jakóbisiak M.
    Int J Cancer; 1998 Aug 31; 77(5):720-7. PubMed ID: 9688305
    [Abstract] [Full Text] [Related]

  • 10. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993 Aug 31; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 11. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K, Sekido S, Araki T.
    Gan To Kagaku Ryoho; 1984 Jun 31; 11(6):1315-23. PubMed ID: 6428326
    [Abstract] [Full Text] [Related]

  • 12. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Jun 31; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA, Wodinsky I.
    Cancer; 1983 Feb 15; 51(4):600-5. PubMed ID: 6401590
    [Abstract] [Full Text] [Related]

  • 14. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS, MUSSER EA, BOSTWICK L, MENGEL GD.
    Cancer Res; 1964 Aug 15; 24():1285-93. PubMed ID: 14216163
    [No Abstract] [Full Text] [Related]

  • 15. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 16. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL, Roberts D.
    Cancer Res; 1977 Mar 15; 37(3):678-83. PubMed ID: 837368
    [Abstract] [Full Text] [Related]

  • 17. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T, Nagahata T, Arakawa M, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Jul 15; 17(7):1351-6. PubMed ID: 2114829
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F, Svarch E, Eppinger-Helft M, Braier JL, Pavlovsky S, Guman L, Vergara B, Ponzinibbio C, Failace R, Garay GE, Bugnard E, Ojeda FG, De Bellis R, de Sijvarger SR, Saslavsky J.
    Cancer; 1978 Oct 15; 42(4):1730-40. PubMed ID: 101296
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F, Vietti T, Coulter D.
    J Natl Cancer Inst; 1980 Apr 15; 64(4):801-5. PubMed ID: 6928994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.